<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ901228-0010</DOCNO><DOCID>901228-0010.</DOCID><HL>   Technology:   Belgium to Ban Painkiller   Made by Roussel of France   ----   Special to The Wall Street Journal</HL><DATE>12/28/90</DATE><SO>WALL STREET JOURNAL (J), PAGE 10</SO><CO>   EUROP F.ROU</CO><IN>DRUG MANUFACTURERS (DRG)</IN><LP>   BRUSSELS -- The Belgian health secretary announcedyesterday he has decided to ban the popular French painkillerGlifanan, made by Laboratoires Roussel, the Belgiansubsidiary of French group Roussel-UCLAF, from the Belgianmarket starting Dec. 31.   The company announced earlier yesterday that it waswithdrawing the drug, which has been on the market for atleast 13 years.</LP><TEXT>   A statement from Health Secretary Roger Delizee said otheranalgesics Exidol, Glafenic and Nalfogan, which containGlafenine like Glifanban, were also banned.   The statement said Glifanan had been investigated byBelgian and European drug experts since 1977. It said alldrugs containing Glafenine had been on free sale until 1987,when experts advised to use them under medical control.   Although the European Community's drug committee did notrecommend immediate precautions, the statement said, Mr.Delizee asked Belgian experts to pursue their investigationin cooperation with the drug makers.   The investigation was completed in July and led Delizee todecide the ban on Glafenine.   A spokesman for Mr. Delizee confirmed press reports thattwo people had died from taking Glifanan without medicaladvise. The Belgian radio said a hundred other people hadsuffered severe secondary effects.   In France, however, the health ministry did not plan toban Glifanan immediately, according to official sources.</TEXT></DOC>